Your session is about to expire
← Back to Search
Ringer Catheter for Coronary Artery Perforation
Study Summary
This trial is to show that a Ringer catheter is a safe and effective way to manage bleeding from a coronary vessel perforation while still allowing blood flow to the rest of the body.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Experimental Arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many applicants are being accepted into the clinical trial at this time?
"This investigation needs 30 compliant participants, who fit the predetermined standards of inclusion. People from University of Washington Medical Center in Seattle and Emory Heart & Vascular Center in Boston are eligible to take part."
How widespread is the implementation of this investigation?
"6 clinical trial sites are presently recruiting patients, based in metropolitan areas such as Seattle, Boston and Detroit. It is recommended that individuals select the nearest location to reduce the amount of necessary travel if they choose to partake."
Is this empirical research open to recruitment?
"Affirmative. The clinical trial page posted on clinicaltrials.gov states that the study, which was initially published in July of 2022, is presently searching for participants. A total of 30 patients must be recruited from 6 distinct medical sites."
Share this study with friends
Copy Link
Messenger